Bill Texts: NY A08253 | 2019-2020 | General Assembly

Bill Title: Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs.

Spectrum: Moderate Partisan Bill (Democrat 29-6)

Status: (Introduced - Dead) 2020-01-08 - referred to health [A08253 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2019-06-10HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New York A08253

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New York A08253 currently on file.

Social Comments on NY A08253

feedback